Influenza A and influenza B are the two types of flu virus responsible for seasonal epidemics, and while they cause nearly identical symptoms, they differ in important ways: how they mutate, which species they infect, when they peak during flu season, and whether they can trigger a pandemic. If you’ve been diagnosed with one or the other, the practical difference in how sick you’ll feel is smaller than you might expect.
How the Two Viruses Are Classified
Influenza A viruses are divided into subtypes based on two proteins on their surface. There are 18 versions of one protein and 11 of the other, creating a huge number of possible combinations. The subtypes you hear about most, H1N1 and H3N2, are the ones currently circulating in people. That naming system (the H and N numbers) applies only to influenza A.
Influenza B works differently. It isn’t broken into subtypes at all. Instead, it’s split into two lineages: B/Victoria and B/Yamagata. B/Yamagata hasn’t been detected in circulation since March 2020, which is why flu vaccines in the United States shifted from four components to three for the 2024-2025 season. Current vaccines protect against an H1N1 strain, an H3N2 strain, and a B/Victoria lineage virus.
Animal Hosts and Pandemic Risk
This is the most consequential difference between the two types. Influenza A has a natural reservoir in wild aquatic birds, and it also infects pigs, horses, dogs, and other animals. That broad host range matters because when the virus replicates in different species, it can pick up entirely new surface proteins in a process called antigenic shift. If a dramatically new version of influenza A jumps to humans, most people have no preexisting immunity, and the result can be a pandemic. All four flu pandemics in the past century were caused by influenza A viruses.
Influenza B, by contrast, circulates almost exclusively in humans. Without that animal reservoir, it doesn’t undergo the same dramatic reassortment events. It still mutates gradually over time through smaller, incremental genetic changes (a process both types share, called antigenic drift), but it lacks the machinery to produce a sudden, radically new virus. That’s why influenza B has never caused a pandemic.
When Each Type Peaks
During a typical flu season, influenza A tends to dominate earlier, often peaking in the winter months. Influenza B usually circulates later, with activity peaking in the spring. In some years the two waves overlap significantly, and in others influenza B barely shows up at all. This timing pattern means that if you catch the flu in February, it’s more likely to be type A, while a case in April is more likely to be type B. But either type can appear at any point in the season.
Severity Is Surprisingly Similar
Many people assume influenza A is automatically more dangerous because of its pandemic potential, but the data on seasonal illness tells a different story. A CDC study examining over 24,000 flu-related hospitalizations across eight flu seasons (2005-2013) found that influenza B caused equally severe disease outcomes as influenza A in hospitalized adults. The length of hospital stays, the proportion of patients admitted to intensive care, and the proportion of deaths were all comparable between the two types.
The symptoms themselves are essentially the same regardless of type: fever, body aches, cough, fatigue, sore throat, and sometimes vomiting or diarrhea. You cannot tell whether you have flu A or flu B based on how you feel. A diagnostic test is the only way to know.
How Testing Works
Rapid flu tests available in most clinics and urgent care centers can distinguish between influenza A and influenza B within about 15 minutes. These tests are quite good at confirming a positive result, with specificity of at least 95% for both types. Their sensitivity, the ability to catch a true case, is somewhat lower. FDA-cleared rapid tests are required to detect at least 80% of influenza A and 80% of influenza B infections compared to the gold-standard molecular tests.
That gap means rapid tests occasionally miss real infections, producing a false negative. If your rapid test comes back negative but your doctor strongly suspects the flu based on your symptoms and what’s circulating in your area, a more sensitive molecular test (PCR) may be recommended. Knowing the specific type can sometimes guide treatment decisions, since antiviral medications work against both A and B but may be prioritized differently depending on community surveillance data.
Why the Distinction Matters for You
For most people dealing with a single bout of the flu, the type matters less than the timing. Antiviral treatment is most effective when started within 48 hours of symptom onset, regardless of whether you have A or B. The annual flu vaccine is designed to cover the dominant strains of both types circulating that season, so vaccination remains the most practical form of protection against either one.
Where the distinction becomes significant is at the population level. Because influenza A can swap genetic material between human and animal strains, it’s the type that public health agencies monitor most closely for the emergence of a novel virus. The World Health Organization requires countries to report any human infection with a new influenza A subtype within 24 hours. Influenza B, while capable of causing severe illness and contributing to seasonal epidemics, simply doesn’t carry that same wildcard potential.